Legal Representation
Attorney
Maria R. Fruci
USPTO Deadlines
Next Deadline
52 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
March 02, 2026
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2026 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jan 2, 2026 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 17, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 17, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 17, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 16, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 16, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 16, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 17, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 17, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 17, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 8, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 8, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Software as a service (SAAS) services featuring software for project management and data tracking tool, optimized for municipal and county government workflows to monitor and execute the grants lifecycle from identification of funding opportunities to closeout of grant awards.; Providing online non-downloadable computer software platforms for project management and data tracking tool, optimized for municipal and county government workflows to monitor and execute the grants lifecycle from identification of funding opportunities to closeout of grant awards.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GRANT"